ONCAlert | 2018 ASCO Annual Meeting
Videos  >  

An Overview of an Immuno-Oncology Panel for Standardized Profiling of Immune Status

Ralf Huss, MD
Published Online:2:55 PM, Wed November 15, 2017

Ralf Huss, MD, Chief Medical Officer of Definiens, discusses a new immuno-oncology panel introduced by Definiens during the The Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting. The goal of the panel is to standardize the immunoprofiling of tumors to better predict response to immuno-oncology treatment.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.